Placeholder. A new monoclonal antibody injectable treatment for canine allergic and atopic dermatitis just launched — the same class of biologic drug technology increasingly used in human medicine, now reaching veterinary allergy treatment.
What we've found so far: A new mAb (monoclonal antibody) injection for canine allergic/atopic dermatitis launched in May 2026, reported in veterinary trade press.
Open research: Identify the specific manufacturer and drug name (not fully confirmed in this research pass); interview a veterinary dermatologist on how this compares to existing treatments like Apoquel/Cytopoint.